ArticleHaematologica2013
Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation.
Article in Haematologica, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia.Annals of hematology · 2014Guideline
- Approach to Hairy-Cell Leukemia in the New Therapeutic Era with Special Emphasis on Age and Comorbidities.Acta haematologica · 2026Review
- Article
- Review
- Interdigitating Dendritic Cell Tumor of Submandibular Lymph Node: Case Report and Literature Review.Iranian journal of pathology · 2021Article
- Computational Approaches in Theranostics: Mining and Predicting Cancer Data.Pharmaceutics · 2019Review
- BRAF in the cross-hairs.Expert review of hematology · 2019Review
- Recent advances in understanding and managing hairy cell leukemia.F1000Research · 2018Review
- Article
- ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngioma.European journal of endocrinology · 2016Review
- BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment.Investigational new drugs · 2015Article
- Hairy cell leukemia: update and current therapeutic approach.Current opinion in hematology · 2015Review
- [Hairy cell leukemia].Der Internist · 2015Review
- Current and emerging treatment options for hairy cell leukemia.OncoTargets and therapy · 2015Review
- Successful re-treatment of a relapsed V600E mutated HCL patient with low-dose vemurafenib.Oncoscience · 2015Article
- Treatment of refractory hairy cell leukemia with a BRAF-inhibitor: lessons to be learnt.Pathology oncology research : POR · 2014Article
- Role of BRAFV600E in the first preclinical model of multifocal infiltrating myopericytoma development and microenvironment.Journal of the National Cancer Institute · 2014Article
- Update on the biology and treatment options for hairy cell leukemia.Current treatment options in oncology · 2014Review
- Hairy cell leukemia: short review, today's recommendations and outlook.Blood cancer journal · 2014Article
- Hairy cell leukemia - immunotargets and therapies.ImmunoTargets and therapy · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.